Catheter Injectable Hydrogel-Based Scaffolds for Tissue Engineering Applications in lung disease

Area of Science:

• Biomaterials Engineering
• Regenerative Medicine
• Pulmonary Medicine

Background:

• Chronic lung diseases like emphysema and pulmonary fibrosis are a leading cause of global mortality.
• Current treatments focus on symptom management, disease slowing, and lung transplantation.
• Regenerative medicine offers a potential alternative for lung repair and regeneration.

Purpose of the Study:

• To engineer a dual-action platform for lung therapy.
• To develop a scaffold for remodeling pulmonary architecture (lung volume reduction).
• To create a platform for regenerating lost respiratory tissue.

Main Methods:

• Developed a hydrogel scaffold using natural polymers: gelatin and alginate.
• Engineered the scaffold for injection through long catheters via a bronchoscope.
• Assessed scaffold properties for lung volume reduction and tissue regeneration capabilities.

Main Results:

• The gelatin-alginate hydrogel scaffold demonstrated suitable physical and mechanical properties for dual objectives.
• Biocompatibility testing on human fibroblasts and mouse mesenchymal cells showed high viability (>70%) up to 7 days post-injection.
• Successful catheter-based delivery of the scaffold was confirmed.

Conclusions:

• The catheter-injectable hydrogel scaffold combines tissue engineering with minimally invasive procedures.
• This offers an inexpensive and convenient alternative to existing scaffolds for lung tissue engineering.
• The novel concept holds potential for broader clinical applications in regenerative medicine.